Publique en esta revista
Información de la revista
Vol. 57. Núm. S2.
COVID-19
Páginas 68-70 (Abril 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
...
Vol. 57. Núm. S2.
COVID-19
Páginas 68-70 (Abril 2021)
Letter to the Editor
DOI: 10.1016/j.arbres.2021.01.021
Acceso a texto completo
High Altitude and COVID-19: A Relationship Difficult to Assess
Altura y COVID-19: una relación difícil de evaluar
Visitas
...
Jesus Perez-Castilla
School of Medicine, Universidad Nacional San Antonio Abad del Cusco, Cusco, Peru
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (1)
Table 1. Epidemic stages according to Farr's Law in Peruvian regions.
Texto completo
Dear Editor,

We have read with tremendous interest the letter by Accinelli and colleagues,1 where through an ecological study they determined the relationship between COVID-19 incidence and altitude in Peruvian cities. This study adds to the growing body of evidence that altitude is related to a decreased infection and mortality rate. However, there are some key points about the context of the pandemic COVID-19 in Peru that the authors did not discuss but are critical to consider before reaching conclusions.

Firstly, serological testing predominates over Polymerase Chain Reaction (PCR) tests to diagnose COVID-19 in Peruvian patients. Until 31st May, 77.91% of the COVID-19 cases in Peru were diagnosed through serological tests. Serological tests have a low sensibility and specificity for the diagnosis of COVID-19,2 and without the possibility of performing PCR tests on all patients, many may remain undiagnosed. This undiagnosed rate may be higher in altitude cities because the capital of the country and sea-level cities have most laboratories that could perform PCR tests.3

Another key point is that the data center of the health ministry has a delay in processing COVID-19 cases and deaths from all regions across the country, which explains the addition and constant update to the number of the statistics from previous months in the registry of the ministry of health.4 Furthermore, currently, the number of cases and deaths in the national registry differs from the ones according to the regional governments.4 Thus, we believe that it would be better to use regional registries in ecological studies rather than the data presented by the health ministry of Peru.

Finally, the COVID-19 pandemic in Peru did not have the same behavior in all cities. To support this information, we performed an analysis of the main cities in Peru with open data from the government,5 using new COVID-19 cases reported from May 27 to May 31. Using Farr's Law,6 I performed an exploratory analysis calculating the R1 and R2 to analyze the behavior of the pandemic in that specific moment; we classified the pandemic stage as: A or B if the pandemic was accelerating; C if the had reached the peak (considered as R1 and R2 between 0.8 and 1.2); D or E if the pandemic was decelerating in that city. As can be seen in Table 1, all regions had different ratios meaning they were at different stages of the pandemic. In a cross-sectional analysis as performed by Accinelli and colleagues,1 the different stages of the pandemic across Peru would be seen as a relationship between altitude and the incidence of COVID-19 cases but performing an analysis with Farr's Law provides enough information to refute this hypothesis. The spurious correlation found by the mentioned study could be the result of the better accomplishment of the quarantine of these cities during the early days of this pandemic. Finally, it is important to remember that ecological studies, such as the one conducted by Accinelli et al, do not consider many other factors that play a role in the incidence of COVID-19; furthermore, they are prone to “ecological fallacy”, where the inferences made with aggregated data are contradictory to those obtained through individual data.7

Table 1.

Epidemic stages according to Farr's Law in Peruvian regions.

Region  R1 and R2  Value  Epidemic stage  Basic interpretation 
>1500 mamsl of altitude
PASCOR1  0.85  DDeceleration
R2  3.55 
JUNINR1  0.76  EDeceleration
R2  0.84 
PUNOR1  0.73  EDeceleration
R2  0.56 
HUANCAVELICAR1  0.71  DDeceleration
R2  1.40 
CUSCOR1  1.24  BAcceleration
R2  0.27 
ANCASHR1  1.07  BAcceleration
R2  0.78 
AYACUCHOR1  0.57  DDeceleration
R2  5.30 
CAJAMARCAR1  1.60  BAcceleration
R2  0.56 
APURIMACR1  1.13  BAcceleration
R2  0.89 
AMAZONASR1  1.30  BAcceleration
R2  0.89 
AREQUIPAR1  1.00  DDeceleration
R2  0.55 
HUANUCOR1  0.75  EDeceleration
R2  0.40 
<1500 mamsl of altitude
MOQUEGUAR1  0.44  DDeceleration
R2  1.58 
SAN MARTINR1  1.02  CPeak of the curve
R2  1.19 
TACNAR1  3.09  BAcceleration
R2  0.65 
ICAR1  0.63  EDeceleration
R2  0.58 
LIMAR1  0.84  CPeak of the pandemic
R2  0.97 
UCAYALIR1  1.19  CPeak of the curve
R2  1.01 
MADRE DE DIOSR1  2.00  BAcceleration
R2  0.22 
LORETOR1  0.56  DDeceleration
R2  1.06 
PIURAR1  0.82  CPeak of the curve
R2  0.90 
LAMBAYEQUER1  0.62  DDeceleration
R2  2.17 
LA LIBERTADR1  1.71  BAcceleration
R2  0.63 
TUMBESR1  1.84  BAcceleration
R2  0.37 
CALLAOR1  1.00  EDeceleration
R2  0.70 

Ministerio de Salud. n.d. “Fallecidos Por COVID-19.” Plataforma Nacional de Datos Abiertos. Peru. https://www.datosabiertos.gob.pe/dataset/fallecidos-por-covid-19-ministerio-de-salud-minsa.

Authors’ contribution

JPC participated in conceptualization, data collection; writing – original draft; writing – review & editing, reviewed the final manuscript and accepted all responsibility for the information provided.

Funding

This study was funded by the authors.

Conflict of interest

JPC declare to have no conflict of interest.

References
[1]
R.A. Accinelli, J.A. Leon-Abarca.
At high altitude COVID-19 is less frequent: the experience of Peru.
Arch Bronconeumol [Internet], (2020 Jul 16),
[2]
M. Lisboa Bastos, G. Tavaziva, S.K. Abidi, J.R. Campbell, L.-P. Haraoui, J.C. Johnston, et al.
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.
BMJ, 370 (2020), pp. m2516
[3]
Laboratorios que realizan pruebas moleculares para el diagnóstico de SARS CoV-2 (COVID-19) [Internet]. Available from: https://web.ins.gob.pe/es/prensa/noticia/laboratorios-que-realizan-pruebas-moleculares-para-el-diagnostico-de-sars-cov-2 [cited 10.11.20].
[4]
Salud Con Lupa. Así trabaja el equipo que corrige el registro de fallecidos por COVID-19 en Perú [Internet]. Available from: https://saludconlupa.com/noticias/asi-trabaja-el-equipo-que-corrige-el-registro-de-fallecidos-por-covid-19-en-peru/ [cited 10.11.20].
[5]
Ministerio de Salud. Fallecidos por COVID-19 [Internet]. Plataforma Nacional de Datos Abiertos. Peru; Available from: https://www.datosabiertos.gob.pe/dataset/fallecidos-por-covid-19-ministerio-de-salud-minsa.
[6]
K. Pacheco-Barrios, A. Cardenas-Rojas, S. Giannoni-Luza, F. Fregni.
COVID-19 pandemic and Farr's law: a global comparison and prediction of outbreak acceleration and deceleration rates.
PLOS ONE, 15 (2020), pp. e1750239
[7]
A.J. Idrovo.
Three criteria for ecological fallacy.
Environ Health Perspect, 119 (2011), pp. A332
Copyright © 2021. SEPAR
Idiomas
Archivos de Bronconeumología

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?